Aimée Kreimer (United States of America)
National Cancer Institute, National Institutes of Health Division of Cancer Epidemiology and Genetics
Moderator of 1 Session
Session Type
Public Health Oral Session
Session Time
07:30 - 08:20
[{"name":"EFFICACY AND IMMUNOGENICITY OF A SINGLE HPV VACCINE DOSE COMPARED TO NO VACCINATION OR STANDARD TWO\/THREE-DOSE REGIMENS: A SYSTEMATIC REVIEW OF EVIDENCE FROM CLINICAL TRIALS \u003Csmall\u003E(ID 1175)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1175,"presentation":"EFFICACY AND IMMUNOGENICITY OF A SINGLE HPV VACCINE DOSE COMPARED TO NO VACCINATION OR STANDARD TWO\/THREE-DOSE REGIMENS: A SYSTEMATIC REVIEW OF EVIDENCE FROM CLINICAL TRIALS \u003Csmall\u003E(ID 1175)\u003C\/small\u003E","session":"Oral Session 9: VACCINATION IV. Strategies and schedules","presenter":"Hilary S. Whitworth (United Kingdom)","photo":""},"playlist":[{"name":"EFFICACY AND IMMUNOGENICITY OF A SINGLE HPV VACCINE DOSE COMPARED TO NO VACCINATION OR STANDARD TWO\/","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/41\/Hilary Whitworth - IPVC20 - 1175.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/41\/Hilary Whitworth - IPVC20 - 1175.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/41\/D6AB0AA8.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/41\/Hilary Whitworth - IPVC20 - 1175.vtt"}]},{"name":"THE IMPACT OF INTRODUCING HPV VACCINE FUNDING FOR BOYS ON ACCEPTANCE AND UPTAKE: EVIDENCE FROM A NATURAL EXPERIMENT IN CANADA \u003Csmall\u003E(ID 629)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":629,"presentation":"THE IMPACT OF INTRODUCING HPV VACCINE FUNDING FOR BOYS ON ACCEPTANCE AND UPTAKE: EVIDENCE FROM A NATURAL EXPERIMENT IN CANADA \u003Csmall\u003E(ID 629)\u003C\/small\u003E","session":"Oral Session 9: VACCINATION IV. Strategies and schedules","presenter":"Zeev Rosberger (Canada)","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/ipvc20\/persons\/photos\/1984.jpg"},"playlist":[{"name":"THE IMPACT OF INTRODUCING HPV VACCINE FUNDING FOR BOYS ON ACCEPTANCE AND UPTAKE: EVIDENCE FROM A NAT","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/41\/Zeev Rosberger_ P629_S980_THE IMPACT OF INTRODUCING HPV VACCINE FUNDING FOR BOYS ON ACCEPTANCE AND UPTAKE EVIDENCE FROM A NATURAL EXPERIMENT IN CANADA.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/41\/Zeev Rosberger_ P629_S980_THE IMPACT OF INTRODUCING HPV VACCINE FUNDING FOR BOYS ON ACCEPTANCE AND UPTAKE EVIDENCE FROM A NATURAL EXPERIMENT IN CANADA.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/41\/D0FE8B6B.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/41\/Zeev Rosberger_ P629_S980_THE IMPACT OF INTRODUCING HPV VACCINE FUNDING FOR BOYS ON ACCEPTANCE AND UPTAKE EVIDENCE FROM A NATURAL EXPERIMENT IN CANADA.vtt"}]},{"name":"HPV VACCINATION COVERAGE IN THREE DISTRICTS IN ZIMBABWE FOLLOWING NATIONAL INTRODUCTION OF 0,12 MONTH SCHEDULE AMONG 10-14 YEAR OLD GIRLS \u003Csmall\u003E(ID 1229)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1229,"presentation":"HPV VACCINATION COVERAGE IN THREE DISTRICTS IN ZIMBABWE FOLLOWING NATIONAL INTRODUCTION OF 0,12 MONTH SCHEDULE AMONG 10-14 YEAR OLD GIRLS \u003Csmall\u003E(ID 1229)\u003C\/small\u003E","session":"Oral Session 9: VACCINATION IV. Strategies and schedules","presenter":"D. Scott LaMontagne (United States of America)","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/ipvc20\/persons\/photos\/97.jpg"},"playlist":[{"name":"HPV vaccination coverage in three districts in Zimbabwe following national introduction of 0,12-mont","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/41\/Scott LaMontagne - IPVC20 - 1229 - HPV vaccination coverage in three districts in Zimbabwe.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/41\/Scott LaMontagne - IPVC20 - 1229 - HPV vaccination coverage in three districts in Zimbabwe.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/41\/2AE75E2B.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/41\/Scott LaMontagne - IPVC20 - 1229 - HPV vaccination coverage in three districts in Zimbabwe.vtt"}]},{"name":"A SINGLE DOSE HPV VACCINATION CAMPAIGN IN GRADE 10 GIRLS IN A DISTRICT IN SOUTH AFRICA: COVERAGE AND CORRELATES \u003Csmall\u003E(ID 1334)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1334,"presentation":"A SINGLE DOSE HPV VACCINATION CAMPAIGN IN GRADE 10 GIRLS IN A DISTRICT IN SOUTH AFRICA: COVERAGE AND CORRELATES \u003Csmall\u003E(ID 1334)\u003C\/small\u003E","session":"Oral Session 9: VACCINATION IV. Strategies and schedules","presenter":"Sinead Delany-Moretlwe (South Africa)","photo":""},"playlist":[{"name":"A SINGLE DOSE HPV VACCINATION CAMPAIGN IN GRADE 10 GIRLS IN A DISTRICT IN SOUTH AFRICA: COVERAGE AND","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/41\/IPVC 20 - P1334 - S830 - Sinead Delany-Moretlwe.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/41\/IPVC 20 - P1334 - S830 - Sinead Delany-Moretlwe.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/41\/D9DA8FAC.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/41\/IPVC 20 - P1334 - S830 - Sinead Delany-Moretlwe.vtt"}]}]
{"type":2,"code":"9E32UU0H"}
[session]
[presentation]
[presenter]
